Thompson Cancer Survival Ctr Foundation

Filing Period

Jan 1, 2011 to Dec 31, 2011

Signed

Nov 7, 2012

Return Version

2011v1.2

Gross Receipts

$1,664,373

Mission

Major Activities

Activity 2

Social Services Operating Grant. See Schedule O.Expenses $388,720, including Grants of $388,720.The Foundation made a grant to support the operations of the Social Services Department of the Thompson Cancer Survival Center. In 2011, the Social Services Department reported 1,759 new patients and 3,701 follow-up patients. Additionally, 854 new patients and 2,311 follow-up patients were provided with nutritional counseling and education. Thompson Cares, a fund to assist patients in crisis situations, provided emergency funding for 357 patients to aid with food, shelter, transportation and other needs. The Social Services Department includes a Genetics Clinic staffed by two licensed and certified genetic counselors who provide breast cancer and hereditary cancer risk assessments and who coordinate genetic testing. In 2011, the Genetics Clinic counseled 331 new patients, including 224 who pursued genetic testing. Of those, 12.9% tested positive for a hereditary cancer syndrome. Whether patients tested positive or negative for a hereditary cancer syndrome, decided not to pursue testing, or were not appropriate candidates for testing, they and their families were able to make informed decisions regarding their medical management based on the genetic counseling they received.

Activity 3

Clinical Trials Operating Grant. See Schedule O.Expenses $311,316, including Grants of $311,316.TCSC Foundation provides an operating grant to the Thompson Cancer Survival Center ("TCSC" or "Thompson") for its Clinical Trials program. Without the support of the TCSC Foundation, there would be no TCSC Clinical Trials program, and TCSC could not offer the valuable, often life changing, treatment opportunities to the patients which it has the privilege of serving. Mission and Priorities: The program's primary mission is to promote access to cancer trials to Covenant Health System constituents in an effort to conquer cancer through clinical research. Clinical trials are an essential means of discovering more effective and safer treatments for cancer patients. Involvement in trials offers an improved means of health strategies for individuals at risk for certain cancers, as well as access to proven standard cancer treatments and new, developing cutting edge therapies for those diagnosed with cancer. Today's clinical trials are tomorrow's standard of cancer care.The Clinical Trials Department's priority is to become the leader in oncology research in the community. This will be achieved through the following measures: 1) by increasing access to clinical trials for patients in East Tennessee and the region through the provision of staff support to regional TCSC facilities; 2) by facilitating improved physician participation throughout all Thompson locations; 3) by increasing the number of available trials; 4) by increasing marketing efforts to promote clinical trials; 5) by opening additional satellite sites to clinical trials participation; and 6) by increasing screening efforts and tumor board conference attendance for all TCSC locations. The TCSC Clinical Trials program seeks to best serve patients in the community and contribute to the success of Thompson Cancer Survival Center and the Covenant Health system as a whole by staying true to the Thompson mission to "...lead to the cure through world class services focused on wellness, patient care and the celebration of survival," of which the TCSC clinical trials program is deeply routed. Doing so will increase referrals locally and regionally, and give current patients the ability to be treated with state-of-the-art care in their own community, not hundreds of miles from home in unfamiliar surroundings - away from their families and support systems.Research Operations Staffing: The Clinical Trials Department enjoys the support of the TCSC Foundation in providing clinical research coordination and fulfillment of regulatory compliance through the following staff efforts: * Manager * Clinical Research Nurse Coordinators * Clinical Research Associate * Regulatory Research Specialist Current Status of TCSC's Clinical Trials Program: * 25 open trials * 42 active treatment patients * 349 patients in follow-upIn 2011, TCSC Clinical Trials Department screened 1,185 patients for clinical trials participation and enrolled 29 patients in oncology clinical trials. Increased efforts have been made to attend Methodist Medical Center, Blount, Sevier and Parkwest tumor board meetings. To help with screening efforts, Research Nurse Coordinators have been assigned to specific physician schedules for screening and to specific locations for coverage, including TCSC's Oak Ridge, Sevierville, West, and Blount sites. The department added the TCSC Sevierville satellite location to clinical trials participation in 2011, and has plans to open up additional satellite locations in Lenoir City, Morristown, Rockwood, and Crossville in the near future. Doing so will require funding, physician and staffing support. Specifically, staffing support will allow for increased regulatory efficiency (which will enable the department the ability to process, open and manage an increased number of new clinical trial studies) and satellite research coordinator presence. Increasing physical nursing presence and support at sate

Filer

EIN

58-2130450